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Since its original description in the 1950s, surgi-
cal repair of abdominal aortic aneurysms (AAA) has
become a safe and durable intervention. Although
initial operative deaths were high, advances in tech-
nique and an improved understanding of the physi-
ology of aneurysm repair rapidly produced
substantial improvements in outcome. 
Over the past 20 years, there have been a num-
ber of additional medical advances that should have
a favorable impact on our ability to detect and treat
abdominal aneurysms. Diagnostic imaging modali-
ties including ultrasound scan, computerized axial
tomography, and magnetic resonance angiography
(MRA) allow earlier detection of smaller and
asymptomatic aneurysms that escape diagnosis
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Purpose: Over the past 20 years, there have been numerous advances in our ability to
detect and to treat abdominal aortic aneurysms (AAAs). We hypothesized that these
advances would lead to (1) an increase in the rate of elective repair and a decrease in
the incidence of ruptured AAA (rAAA) and (2) a decrease in operative deaths for
both elective AAA (eAAA) and rAAA. 
Methods: To test these hypotheses, we investigated the incidence and outcomes of eAAA
and rAAA surgery between 1979 and 1997, using the National Hospital Discharge
Survey. This data set is a randomized, stratified sample representing discharges from
the nation’s acute care, nonfederally funded hospitals. Codes from the International
Classification of Diseases, Ninth Revision were used to identify our study population. 
Results: Over the past 19 years, there has been no change in the incidence rate of
eAAA repair (range, 44.1-77.9 per 100,000). Moreover, the incidence of rAAAs pre-
senting to the nation’s hospitals has not changed (range, 6.6-16.3 per 100,000).
There has been no consistent improvement over time in operative deaths associated
with either eAAA or rAAA repair (average rates over the study period: eAAA, 5.6%;
rAAA, 45.7%). Significant predictors of death from eAAA in patients included an age
older than 80 years, African American race, congestive heart failure (CHF), and dia-
betes (P < .0001 for all). Significant predictors of death from rAAA in patients
included age older than 70 years, African American race, female sex, renal failure, and
a hospital bed size more than 500 (P < .05 for all).
Conclusion: On a national level, over the past 19 years, our ability to identify and to
treat patients with AAA has not improved. Advances in technology and critical care
have not affected outcome. Regionalization of care, screening of high-risk popula-
tions, and endovascular repair are strategies that might allow further improvement in
the outcome of patients with aneurysmal disease. (J Vasc Surg 2000;32:1091-100.)
through physical examination. Our ability to pre-
pare patients for aneurysm repair has also
improved. Preoperative identification of concomi-
tant atherosclerotic disease, particularly in the cere-
bral and cardiac circulations, allows institution of
measures to prevent postoperative complications
such as stroke and myocardial infarction. Gains
have also been made in the perioperative treatment
of patients with aneurysmal disease. The introduc-
tion of the Swan-Ganz catheter, the cell-saver,
epidural analgesia, retroperitoneal exposure, and
transesophageal echocardiography have all been
proposed as measures that improve the intraopera-
tive care of patients undergoing aneurysm repair.
Finally, advances in intensive care medicine have
allowed even elderly and infirm patients the poten-
tial to survive this complex surgical procedure.
With these advances in mind, we formulated
the hypothesis that over the past 20 years, our
ability to identify and treat AAAs has improved.
More accurate methods of detection should lead
to earlier diagnosis of aneurysms resulting in (1)
an increase in the incidence of elective aneurysm
repair and (2) a decrease in the number of rup-
tured aneurysms. We also hypothesized that signif-
icant advances in perioperative and critical care
should improve patient outcome, thereby reduc-
ing the operative mortality rate of both elective
and ruptured repairs. Although these questions
have been previously addressed in single institu-
tion and regional studies, a chronologic evaluation
of national trends in aneurysm repair is unavail-
able. To verify our hypotheses, we evaluated the
incidence and outcome of AAA repair in the
United States over a 19-year period using a well-
established national database.
METHODS
The National Hospital Discharge Survey
(NHDS) is a large national data set developed in
1965 by the National Center for Health Care
Statistics. Information for this database is obtained
through evaluation of inpatient records from acute
care, nonfederally funded hospitals. Eligible hospi-
tals include those institutions with at least six beds
where the average length of stay for patients is less
than 30 days. From the nation’s approximately
6000 hospitals, a sample of approximately 500 is
selected on a yearly basis. Hospital discharges are
collected by means of a stratified system that is
based on the annual number of discharges and
geographic location of each institution. These dis-
charges represent approximately one eighth of the
US population.
Two data collection procedures are used. In
two thirds of the hospitals surveyed, information is
obtained by hospital staff who transcribe the data
to the NHDS medical abstract form. This form is
then forwarded to the National Center for Health
Care Statistics for coding, editing, and weighting.
An automated system is used to collect data from
approximately one third of the contributing hospi-
tals. This involves the purchase of data from other
organizations or selected state systems that collect
similar information.
Data collected for each patient includes birth
date, sex, race, ethnicity, marital status, zip code,
and payment source. Also included are codes from
the International Classification of Diseases, Ninth
Revision (ICD-9) for a maximum of seven diag-
noses and four procedures per patient. Data are
also collected with regard to patient outcomes,
length of stay, and disposition.
An ongoing quality control program is under-
taken on a yearly basis whereby approximately 5%
of the data sets are independently reevaluated by an
NHDS coder. Discrepancies are resolved, and the
rate of discrepancy is recorded. For example, the
overall error rate for records manually compiled by
an NHDS coder for the 1991 data year was 2.4%
for diagnostic codings involving the ICD-9 system
and 0.6% for the coding of demographics.1
We identified our study population using the
ICD-9 diagnostic codes for elective AAA (eAAA)
(441.4) and ruptured AAA (rAAA) (441.3) and
the ICD-9 procedural code for AAA repair (38.44)
(when hospitals bill for procedures, an ICD-9 pro-
cedural code is used rather than a code from the
Current Procedural Terminology, which is specific
for physician billing). There is only one ICD-9
procedure code for AAA repair that does not dis-
tinguish between elective and ruptured proce-
dures. To identify patients hospitalized for eAAA
repair, we used the combination of 441.4 (any
diagnosis) and 38.44 (any procedure). When eval-
uating the deaths associated with eAAA, we used
the combination of 441.4 (primary diagnosis) and
38.44 (any procedure). We assumed that the over-
all incidence of rAAA paralleled the rate of hospi-
talization of rAAA, and we used the diagnostic
code 441.3 (any diagnosis) to identify these
patients. To identify patients undergoing repair of
rAAA, we used the combination of 441.3 (any
position) and 38.44 (any position).
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The variables we examined included the year of
admission or procedure, patient age, sex, race,
hospital size, and the following comorbidities uti-
lizing the ICD-9 codes for identification: diabetes
(250), hypertension (401-405), CHF (428), his-
tory of myocardial infarction (410.0-411.0, 412,
414.8), renal failure (584.9, 585, 403.91),
emphysema (492), and tobacco use (305.1). To
evaluate trends over time, we collected data from
1979-1997. We had available to us a complete
data set for this period of time; data from more
recent years are not yet available. With respect to
age, because of the low incidence of AAA in
younger patients, we focused only on patients
older than 50 years. The following age categories
were created: 50 to 59, 60 to 69, 70 to 80, and
older than 80. Race was categorized as white,
African American, American Indian, Asian, other,
or unknown. We examined the effect of hospital
size on operative deaths. Hospitals were stratified
into the following bed size subdivisions: 6 to 99,
100 to 199, 200 to 299, 300 to 499, and more
than 500. Annual volumes for specific surgeons
were unavailable from the NHDS. We evaluated
outcome parameters that included the incidence of
eAAA repair, incidence of rAAA, and operative
deaths associated with eAAA and rAAA.
The technique of linear regression was used in
our model. For the analysis of death, we first exam-
ined data using univariate analysis with the Student
t test for continuous variables and the Fisher exact
test for discrete data. For the multivariable analysis,
variables with a P value less than .25 were entered
into a multiple logistic regression model. The final
logistic model was corrected for overdispersion.
This may occur during modeling of discrete data
when the variance of the response variable exceeds
what is expected. The statistical correction is the
multiplication of all the SEs associated with the risk
factor coefficients by the estimated dispersion para-
meter, which yields adjusted SEs. This will subse-
quently effect the corresponding P values and odds
ratio CIs. Certain variables were then removed
from the original unadjusted model, because of an
overdispersion-adjusted P value of more than .05.
We also tested for interactions.
Yearly incidence rates for rAAA and eAAA were
adjusted by the method of Direct Standardization.
Age-specific population values from the 1990 US
census were used as the standard population. For all
statistical analysis, data were analyzed with the SAS
System software (SAS Institute, Inc, Cary, NC).2
RESULTS
Incidence of eAAA and rAAA 
Over the 19-year study period, 358,521
patients underwent eAAA repair. The median age
at admission for men and women was 70 and 73
years, respectively. Females comprised 22.7% of
the total number of eAAA repairs. Annual varia-
tion of repair rates ranged from 44.1 to 72.9 per
100,000 US population. Although annual fluctua-
tion was observed, no change in the incidence of
eAAA repair over the 19-year period of study was
apparent (Fig 1, A).
From 1979 to 1997, 67,751 patients presented
to this nation’s acute care, nonfederally funded
hospitals with an admission diagnosis of a rAAA.
We evaluated patients with the admitting diagnosis
of rAAA versus those treated operatively so as not
to exclude patients who died en route to the oper-
ating room. The median age for men was 72 years
and for women, 78 years. Over the 19-year study
period, women comprised 22.4% of the total num-
ber of annual admissions for rAAA. Annual rates of
rAAA ranged from 6.6 to 16.3 per 100,000 US
population. Although there was annual fluctuation
in this rate over the 19-year period of observation,
no overall statistical change in the annual incidence
of rAAA was apparent (Fig 1, B).
Operative deaths
Elective AAA. We calculated the annual opera-
tive mortality rate associated with repair of eAAA for
1979 to 1997 (Fig 2, A). The average mortality rate
over this 19-year period was 5.6% with no statisti-
cally significant change during the overall period of
observation. Although we could identify variations
in annual mortality rates, no consistent trend over
the 19 years that were evaluated was apparent. 
Ruptured AAA. We next calculated the annual
operative mortality rate associated with repair of
rAAA for 1979 to 1997 (Fig 2, B). The average
annual operative mortality rate was 45.7%. A
decrease in death was observed over the last 3
years of the period of observation (1994-1997),
suggesting a possible downward trend. However,
overall, no statistically significant decrease in death
for repair of rAAA over the 19 years that were
evaluated was apparent. 
We also determined the percentage of patients
hospitalized with rAAA who died before opera-
tion. This number ranged from 3.7% to 7.2%;
there was no significant change in this incidence
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over the study period. These data suggest that in-
hospital triage and resuscitation efforts have not
improved over the two decades of this study. 
Mortality rate of eAAA repair and associated
variables
Sex. The overall eAAA operative mortality rate
for men and women was 5.1% and 7.7%, respec-
tively. Despite this numerical difference, using
multiple logistic regression we did not find a sta-
tistical association between female sex and opera-
tive death after eAAA repair (Table I).
Age. The following age cohorts were created:
50 to 59, 60 to 69, 70 to 80, and older than 80.
Multivariable analysis revealed a significant increase
in operative mortality for elective repair in the
older-than-80 age group (P < .0001) (Table I).
Race. After the controlling for other variables,
there was a statistically significant increase in elec-
tive operative mortality for African Americans
compared with all other races (P < .0001). The
overall operative mortality rate after eAAA repair
for African Americans was 11.3% versus 5.5% for
whites. The median age at presentation for
African Americans and whites was 73 and 70
years, respectively (Table I).
Bed size. Bed size was stratified into the fol-
lowing subdivisions: less than 100, 100 to 199,
200 to 299, 300 to 499, and more than 500. After
controlling for other variables in multiple logistic
regression, we found that bed size did not predict
operative death after eAAA repair (Table I). 
Comorbidities. We examined the following
comorbidites in our model: CHF, hypertension,
tobacco use, emphysema, type 1 and type 2 dia-
betes mellitus, and renal failure. Patients with
CHF had an increased likelihood of death after
eAAA repair (P < .0001). Diabetes also proved to
be an independent predictor of death (P < .03).
We found that patients with a history of hyperten-
sion were protected against death. Patients with-
out hypertension were more likely to die after
eAAA repair than their hypertensive counterparts
(P < .0003) (Table I).
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Fig 1. A, National trends in incidence of elective aneurysm repair, 1979-1997. Data obtained from
NHDS. Incidence rates are age and population adjusted. B, National trends in incidence of rAAAs,
1970-1997. Data obtained from NHDS. Incidence rates are age and population adjusted.
A
B
Mortality rate of rAAA repair and associated
variables
Sex. Women constituted 22.5% of the entire
cohort. The overall rAAA operative mortality rate
for men and women was 41.6% and 64.8%, respec-
tively (P < .0001) (Table II).
Age. We evaluated death using the following age
cohorts: 50 to 59 years, 60 to 69 years, 70 to 80
years, and older than 80 years. We found a signifi-
cant association between age older than 70 years and
increased operative death (P < .0001) (Table II).
Race. African Americans comprised 4.2% of the
total cohort of ruptured aneurysm repairs. African
Americans presented at a median age of 78 years,
whereas whites presented at a median age of 72
years. We found a significant association between
the African American race and increased operative
death after rAAA repair (P < .0001) (Table II).
Over the 19-year study period, crude operative
mortality rates after rAAA repair were 84.5% for
African Americans and 44.9% for whites (Table II).
Bed size. We found that patients undergoing
repair of a rAAA had a significantly greater likeli-
hood of death in hospitals with less than 500 beds
(P < .0001) (Table II). 
Comorbidities. We examined the following
comorbidites: CHF, tobacco use, emphysema,
type 1 and type 2 diabetes mellitus, and renal fail-
ure. Renal failure was the only comorbidity that
was independently associated with increased death
after rAAA repair (P = .006) (Table II).
DISCUSSION
We initiated this study with the assumption
that technologic advancements and the accrual of
experience over a 19-year period would greatly
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Fig 2. A, National trends in operative death after eAAA repair, 1979-1997. Data obtained from NHDS. B,
National trends in operative death after rAAA repair, 1979-1997. Data obtained from NHDS. (Trends from
1980 and 1981 are not plotted in the graph because of insufficient data in these years). 
A
B
enhance our ability to diagnose and treat AAAs.
We hypothesized that detection of smaller or
asymptomatic aneurysms with ultrasound scan,
computerized axial tomography, or MRA would
increase the rate of elective aneurysm repair and
ultimately decrease the incidence of aneurysm rup-
ture. Moreover, we anticipated that improvements
in the preoperative evaluation and perioperative
care of patients with aneurysms would diminish
operative morbidity and death. Much to our sur-
prise, we found that over the past 19 years there
has been no significant change in (1) the rate of
eAAA repair, (2) the incidence of ruptured
aneurysms presenting to our nation’s hospitals,
and (3) the death associated with repair of either
eAAAs or rAAAs.
These trends have been previously analyzed
with several regional databases and a review of the
nation’s Veterans Administration (VA) hospitals
(Table III).3-9 During the 1980s an increase in the
number of eAAA repairs was noted in Michigan
(24% increase, 1980-1990) and New York (94%
increase, 1982-1987).7,8 However, over similar
time periods there was no change in the frequency
of eAAA repair in California, Maryland, Florida,
and the VA hospital systems.3,5,6,9 With regard to
the incidence of rAAAs, studies revealed increases
in Michigan and New York, but not California,
Florida, Maryland and the nation’s VA hospitals.4-
9 In none of these studies was a decrease in the
incidence of rAAA observed that would be the
logical sequelae of advancements in our ability to
diagnose and treat aneurysmal disease. Death asso-
ciated with eAAA and rAAA repair was addressed
in these same studies. With regard to elective
repair, a decrease was reported in two states
(California, 3% over 12 years, and Michigan, 8%
over 10 years),5,7 but in Maryland, Florida, and
the nation’s VA hospitals, the mortality rate asso-
ciated with elective repair was unchanged during
the periods of observation.3,6,9 For rAAA, with the
exception of Maryland, the incidence of death was
constant over time.4-9 A review of the NHDS
database has been previously published by
Lawrence et al.10 However, in this study, only the
years 1990 and 1994 were reviewed; most of the
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Table I. Predictors of operative death after eAAA repair
Variable Crude mortality rate Odds ratio 95% CI P value
Age > 80 y Age > 80 y: 24.7% 8.3 5.4-12.6 < .0001
Age < 80 y: 3.6%
African American race African American race: 11.3% 3.2 1.1-7.7 .02
White race: 5.5%
CHF CHF: 13.4% 2.9 1.7-4.9 < .0001
No CHF: 5.0%
DM DM: 9.0% 2.2 1-4.5 .03
No DM: 5.5%
CHF, Congestive heart failure; DM, diabetes mellitus; eAAA, elective abdominal aortic aneurysm.
Table II. Predictors of operative death after rAAA repair
Variable Crude mortality rate Odds ratio 95% CI P value
Age > 70 y Age > 70 y: 56.2% 4.8 3-78 < .0001
Age < 70 y: 25.0%
African American race African American race: 84.5% 16.6 3.2-176.8 .003
White race: 44.9%
Female sex Female sex: 64.8% 3 1.7-5.2 < .0001
Male sex: 41.6%
RF RF: 68.7% 2.5 1.3-4.9 .006
No RF: 42.8%
BS < 500 BS < 500: 47.9% 2 1.1-3.6 .019
BS > 500: 34.3%
BS, Bed size; rAAA, ruptured abdominal aortic aneurysm; RF, renal failure.
data were derived from the year 1994. Although a
great amount of information is available from this
analysis, trends in AAA treatment were not evalu-
ated. Although there is significant variation in the
findings of these prior studies, in general, most of
the data support our observation that little
progress has been made over the past two decades
in the diagnosis and treatment of AAA. 
The final common goal when treating
aneurysms is to save lives by preventing rupture.
Although surveillance and treatment programs for
aneurysms can be evaluated with numerous out-
comes, the ultimate end point should be a diminu-
tion in the rate of aneurysm rupture in the
population under study. In this analysis we assume
that the incidence of patients hospitalized with rup-
tured abdominal aneurysms parallels the true inci-
dence of aneurysm rupture. However, the number
of patients hospitalized is likely only a small fraction
of the patients who rupture their aneurysm; most
will die before they can receive medical attention. It
would be impossible, then, to ever acquire data
regarding the true incidence of rAAA because in
patients who die of this disease, the true cause of
death is seldom discovered. Despite our inability to
measure the total number of ruptured aneurysms,
the absence of a reduction in the number of patients
hospitalized for rAAA during the 19-year period of
observation strongly implies that we have made lit-
tle impact on the overall mortality rate associated
with this disease process. 
There are a number of single institution stud-
ies that reveal diminished mortality rates for eAAA
repair. Mortality rates as low as 2% have been
reported by a number of investigators.11-14 How
does one reconcile the discrepancy between these
findings and those on a national level?
Interestingly, for ruptured repairs, lower mortality
rates were associated with institutions with 500 or
more beds. Perhaps large hospitals that are trauma
centers and have both experienced personnel and
advanced triage systems are best able to manage
ruptured aneurysms. Alternatively, larger hospitals
could be referral centers that accept transfer of
patients from the outlying communities. Referral
patients would then be more likely to have “sta-
ble” contained ruptures, an entity that is associ-
ated with a less significant operative mortality rate.
A number of investigators have shown that hospi-
tal and surgeon volume is a critical factor in out-
come after AAA repair.3,5,8,15 Whether it is
hospital size, surgeon experience, or a combina-
tion of the two, our data reveal a dramatic differ-
ence between the national outcomes for AAA
repair and those reported from single institutional
studies. These data would argue strongly for the
need to regionalize care of patients with AAAs.
For both elective and ruptured aneurysm
repair, we discovered that age was a significant
predictor of death. An increased risk for elective
repair was observed in patients older than 80
years. An inverse correlation between age and
death was also observed in patients with rAAA,
although this relationship developed a decade ear-
lier. An association between advancing age and
increasing operative death for both eAAA and
rAAA repair has been documented extensively by
other investigators.3,4,5,8,15
We observed in women a twofold to fourfold
increase in the risk of death from rAAA. However,
we were unable to demonstrate for women an
increase in the operative mortality rate for eAAA.
This relationship has been explored with other
databases. Katz et al,7,16 using data from
Michigan, found an approximately 1.5% increase
in the mortality rate for women undergoing both
eAAA and rAAA repair. Alternatively, Dardik et
al3,4 reported an increased operative mortality rate
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Table III. eAAA and rAAA repair: review of population-based surveys
eAAA eAAA operative rAAA rAAA operative
Study Region Observation (y) incidence mortality rate incidence mortality rate
Dardik et al Maryland 1990-1995 ↔ ↔
Dardik et al Maryland 1990-1995 ↔ ↓ 16%
Manheim et al California 1982-1994 ↔ ↓ 3% ↔ ↔
Kazmers et al Veteran’s hospitals 1991-1993 ↔ ↔ ↔ ↔
Katz et al Michigan 1980-1990 ↑ 24% ↓ 8% ↑ 8% ↔
Hannan et al New York 1982-1987 ↑ 94% ↔ ↑ 68% ↔
Pearce et al Florida 1992-1996 ↔ ↔
among women undergoing eAAA but not rAAA
repair. This and the higher occurrence of comor-
bidities in female patients may account for these
observed higher operative mortality rates. 
To date, the association between race and out-
come after vascular surgical procedures has been
reported in few studies. We discovered that the
mortality rate increases in African Americans after
both eAAA and rAAA repair. Dardik et al,3 using
the Maryland database, also evaluated race as a fac-
tor in eAAA outcome and found that the mortal-
ity rate increased in African Americans after eAAA
but not rAAA repair. Possible explanations for this
increased mortality rate in African Americans may
include (1) a greater number of associated comor-
bidities in African Americans or (2) diminished
access to health care.
Since the 1950s, we have made tremendous
progress in our ability to diagnose and to treat
aneurysmal disease. The lack of continued
progress over the past two decades, however,
should be a stimulus for our specialty to explore
new strategies to improve the care of these
patients. Screening programs for the earlier detec-
tion of AAAs should be considered. Wilmink et
al17 prospectively studied screened and unscreened
populations and found a decrease of 49% in the
incidence of rupture in the screened group.
Although several studies suggest that screening for
AAA is not cost-effective, this issue has not been
addressed in high-risk populations. The use of
endovascular stents may decrease operative death,
particularly in those patients with numerous
comorbidities. Finally, regionalization of the care
of patients with aortic aneurysms may serve to
lower overall operative death and morbidity. 
In summary, we have found that technologic
and treatment advances over the past 19 years have
not had an impact on the outcomes of patients
with AAAs. The use of a national database has
enabled us to evaluate trends over time and also to
examine how surgeons throughout the nation are
performing. Although significant progress has
been made at many individual centers, on a
national level, we should explore strategies that
might lead to further improvements in outcome.
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Dr Bruce J. Brener (Millburn, NJ). My comments will
center around three conclusions presented by the
authors. First, physicians should identify more aneurysms
in the population. Second, the mortality rate for surgery
for elective and ruptured aneurysms has not improved
during the last two decades. And third, women and blacks
have a higher mortality rate than white males. Each of
these messages, if true, is unacceptable. 
The failure of the medical community to easily iden-
tify patients with aneurysms through screening is in my
opinion a failure of communication. It is a failure of
public relations. We have failed to focus attention on
this public health issue. I believe that we are going to
need a public foundation, like the American Heart
Association or the Cancer Association, some American
Vascular Association, to increase awareness of this dis-
ease. Ultrasound examination is accurate and inexpen-
sive. We need to treat this illness as a high-profile disease
like HIV or breast cancer or prostate cancer. I think
that’s the only way we’re going to make any progress.
I’m not surprised that the operative mortality for
aortic resection is not lower; there are so many causes of
postoperative death. For example, we may be selecting
higher-risk patients because we are a little better at peri-
operative management. I’m not sure that major break-
throughs in technique, risk stratification, anesthesia
management, and perioperative care have occurred dur-
ing the 1980s and 1990s. In fact, the major advances
that have lowered the mortality of aortic surgery,
namely, minimal dissection and elimination of resection
of the aorta, occurred in the 1960s and 1970s. While
the use of epidural catheters for pain management has
enhanced aortic surgery, it probably has not affected the
mortality rate. Perhaps the use of endovascular tech-
niques will provide a safer operation.
And finally, our inability to treat women and blacks
with the same safety as white males is an unacceptable
conclusion, and I think it requires some soul-searching
on our part as well as some action. 
I have a few questions. What statistical biases are
present in this kind of methodology? Do you know how
many unoperated aortic aneurysms that are 5 cm or
greater are present in the United States population?
What high-risk groups should be screened for
aneurysms? What changes in medical management do
you think should have lowered the operative mortality
over the last 20 years? Do you think endovascular repair
of aneurysms will lower the mortality of high-risk
patients? Will we be able to use these techniques for aor-
tic aneurysm rupture? 
Dr Jennifer A. Heller. Thank you, Dr. Brener, for
your kind comments and questions. 
I do have to preface my responses to the comments
and questions with the fact that we truly were very sur-
prised with the results that we discovered on this
national database. We truly expected to see some form
of improvement and some progress over time over the
past 19-year period. So this was a very thought-provok-
ing topic for us as well. 
Just briefly in response to some of your initial com-
ments, it is interesting to suggest that the patient popu-
lation as a whole has changed over time, and certainly
there is much literature within our field to suggest that
that is the case. For example, Bredenberg et al report
similar epidemiologic changes in their evaluation of
patients with chronic renal artery occlusive disease.
We tried to counter these problems in our study.
When we examined incidence rates for both elective and
ruptured repairs, we adjusted for age and population.
With regard to the innovations over the past 19 years,
I will contest that there are innovations over the past 19
years that should have actually improved our ability to
certainly treat and to detect aneurysms. With regard to
detection, certainly ultrasound is our gold standard for
diagnostic screening. But the MRA as well as CT angiog-
raphy and other modalities should have been able to pick
up asymptomatic unexpected aneurysms. As well, Bushey
et al in the 1980s discussed in JAMA an innovative way
of noninvasively screening for cardiac disease with the
stress thallium test. And as Hertzer and many others have
described extensively, the prevention and the treatment of
significant coronary disease prior to elective aneurysm
repair certainly improve aneurysm outcome. So I think
that those two issues are significant innovations that need
to be addressed. 
The great advantage about this national dataset is
that it afforded us with the opportunity to examine out-
comes from all surgeons who perform abdominal aortic
aneurysm repair, not just board-certified vascular sur-
geons with more experience and potentially more ancil-
lary resources. And because of this, our data are
different from single institutions studies.
With regard to the statistical biases, however, there
is going to be sampling error. When we performed our
statistical analysis, however, our sampling errors were
relatively small. When we did have cohorts, however,
that did have small sample size, we left them out of the
equation. And that was rare and few between, but we
did do that so that we could prevent any miscoding or
errors that could occur. 
The last issue with regard to statistical bias has to do
with miscoding errors, which, unfortunately, are preva-
lent with every database that exists in this country. This
has been looked at extensively with regards to the
Medicare and Medicaid and the HCFA databases, and
they note a significant amount of miscoding errors, par-
ticularly in the ICD-9 diagnosis areas, and they note rates
as high as 26% to 30%. However, when they did, with
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respect to the HCFA data set, when they took a look at
these coding errors for diagnosis, particularly with AAAs,
they noticed that the accuracy rates were as high as 97%. 
As far as what high-risk groups should be screened,
I think it’s important to take note that there have been
some minimal cost-effective studies that have been per-
formed to examine whether or not ultrasound is a cost-
effective measure. And the subgroups that are at high
risk have not been effectively determined in these analy-
ses. And the subgroups who are at high risk, who should
be analyzed, I believe, are male siblings who have a first-
order relative who has an abdominal aneurysm, males
over 50, any patient who exhibits a smoking history be
it remote or present, as well patients who have manifes-
tations of cardiac as well as peripheral vascular disease. 
Do I believe that endovascular interventions will
improve the outcome in the high-risk patient? I cer-
tainly hope so. I think that we’re early on the horizon in
expecting that, but I think that that’s an exciting
endeavor that we can look to in the future. 
Dr Alan Dardik (Baltimore, Md). I applaud your
study, and I think it’s an excellent one. It reflects on a
national level certainly what we found in Maryland. We
found that the incidences of both elective and ruptured
aneurysm repairs haven’t changed. Our numbers are
remarkably similar to yours on the national level. 
However, we showed for ruptured aneurysms that
mortality has been decreasing. Although we don’t advo-
cate sending all the patients to Maryland, we think that
regionalization of our care may have already occurred in
the state of Maryland and this may be a reason for our
declining mortality. Have you noticed any changes in
hospital volume trends over the course of your study
that might account for this? 
Second, have you noticed any differences between
community and tertiary care institutions in your study? 
Thirdly, we use hospital size really as a surrogate for
surgeon volume and thus, surgical experience. Were you
able to examine this in your database? 
And lastly, I absolutely agree that we should screen
aneurysms. The British literature has demonstrated that it
reduces mortality. The only problem is that the National
Health Service itself doesn’t pay for screening and they
only screen by research protocols, as I understand. How
would we screen our population for aneurysms? 
Thank you. 
Dr Heller. With regard to your questions on regional-
ization of care, the issues that the national hospital dis-
charge survey database has, unfortunately, are very few.
The only characteristic that we were able to obtain was
with respect to hospital bed size. The way the hospitals
initially are brought into the equation is that there is a
national resource of approximately 6000 hospitals in the
nation and then from that a sample size is acquired from
which they obtain their database. And the data are actu-
ally transferred over once they pick the particular hospi-
tals from the nation’s sample. And those hospital
characteristics that you mentioned, unfortunately, are not
recorded. So we can’t do a true “practice makes perfect”
as Hannon did. We can’t take a look at individual sur-
geons. We’re not able to take a look at hospital volumes
with respect to individual cases per year of aneurysms. 
Groups in Britain, particularly Wilmek et al, prospec-
tively studied the effect of mass screening and noticed a
decrease in the rupture repair rate. Certainly, protocols
need to be developed to establish screening programs.
Dr Anton N. Sidawy (Washington, DC). I would like
to express some concern regarding getting data from
these huge databases. Looking at your graphs, actually if
you draw a line across the graphs, it would be a horizon-
tal line, so it will give you the impression that there is no
change in mortality. However, if you compare one time
period to another, the variance in mortality is tremen-
dous: you’re looking at 20% and up to 70%. What did
you do to assure yourself that the data are accurate? 
Dr Heller. Thank you very much, actually, for bring-
ing that up, because it was something that we were very
concerned about as we were investigating this project,
and I didn’t really have time to go into this in detail in
my presentation. 
With respect to trends over time, we were very con-
cerned, as you said, that all we had to really do was draw
a line. We divided our 19-year study period into 5-year
intervals and used the last 3 years of the study as our
baseline for comparison. No changes over time existed,
although variance was observed in one time set versus
another. In addition, our statistical analysis was tested
by using overdispersion.
Dr Anthony J. Comerota (Philadelphia, Pa). That
was a beautiful presentation. 
Could you focus on the use of the odds ratio for an
adverse outcome? Let’s assume that a white with a rup-
tured aneurysm had a mortality of 25%. How could a
black patient have a mortality 14 times that? 
Dr Heller. The odds ratio refers to probablilities or likeli-
hood and is not a representation of numerical comparison.
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